株式会社ヘリオス

Healios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.

株式会社ヘリオス is a business in medtech based in Tokyo, Japan.

Profile

"Healios is a pioneering medtech company dedicated to expanding treatment options for patients worldwide through regenerative medicine. With a mission to deliver new therapies and hope to patients globally, Healios focuses on two main areas of regenerative medicine: iPSC regenerative medicine and somatic stem cell regenerative medicine. Their iPSC regenerative medicine includes universal donor cells, cancer immunotherapy (NK cells), age-related macular degeneration, and liver diseases. On the other hand, somatic stem cell regenerative medicine targets conditions such as stroke and acute respiratory distress syndrome (ARDS). Healios is committed to developing innovative treatments in these fields to enhance patient health and quality of life."

株式会社ヘリオス is positioned in medtech, a segment that rewards a clear, focused offering.

The company is recorded as being based in Tokyo, Japan.

Directory data places it at the Plug and Play portfolio startup stage.

Website: www.healios.co.jp